(Q37917889)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21843576%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

review article

1 reference

title

Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programme (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21843576%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

main subject

tick-borne encephalitis

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21843576%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

4

Sandor Fritsch

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21843576%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

8

Hartmut J Ehrlich

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21843576%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

7

P Noel Barrett

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21843576%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

Alexandra Loew-Baselli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21843576%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Eva Maria Poellabauer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21843576%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Borislava G Pavlova

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21843576%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Robert Petermann

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21843576%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

language of work or name

English

0 references

publication date

16 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21843576%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21843576%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21843576%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

issue

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21843576%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

page(s)

7307-7319

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21843576%20AND%20SRC:MED&resulttype=core&format=json

Occurrence of TBE in areas previously considered being non-endemic: Scandinavian data generate an international study by the International Scientific Working Group for TBE (ISW-TBE).

10 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Tick-borne encephalopathies : epidemiology, diagnosis, treatment and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Tick-borne encephalitis and golden agers: position paper of the International Scientific Working Group on Tick-borne encephalitis (ISW-TBE).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Field effectiveness of vaccination against tick-borne encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Study of the serological response after vaccination against tick-borne encephalitis in Sweden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

7 January 2021

Tick-borne encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

TBE vaccination and the Austrian experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Preparation of a highly purified vaccine against tick-borne encephalitis by continuous flow zonal ultracentrifugation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

7 January 2021

History of TBE vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Albumin is a necessary stabilizer of TBE-vaccine to avoid fever in children after vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Tolerability of modified tick-borne encephalitis vaccine FSME-IMMUN "NEW" in children: results of post-marketing surveillance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Immune function in healthy inner-city children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Clinical evaluation to determine the appropriate paediatric formulation of a tick-borne encephalitis vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Insufficient protection for healthy elderly adults by tetanus and TBE vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

The Golden Agers and Tick-borne encephalitis. Conference report and position paper of the International Scientific Working Group on Tick-borne encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Serological response to tick-borne encephalitis (TBE) vaccination in the elderly--results from an observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Antibody response following administration of two paediatric tick-borne encephalitis vaccines using two different vaccination schedules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Comparison of immunogenicity and safety between two paediatric TBE vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Decreased antibody titers and booster responses in tick-borne encephalitis vaccinees aged 50-90 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Persistence of protective immunity following vaccination against tick-borne encephalitis--longer than expected?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Immunological response in HIV-positive patients vaccinated against tick-borne encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Cellular and humoral immune responses in haemophiliacs after vaccination against tick-borne encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Impaired primary, but not secondary, immune response in breast cancer patients under adjuvant chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Diminished response to tick-borne encephalitis vaccination in thymectomized children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Use of recombinant E protein domain III-based enzyme-linked immunosorbent assays for differentiation of tick-borne encephalitis serocomplex flaviviruses from mosquito-borne flaviviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Siberian subtype tickborne encephalitis virus, Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Molecular epidemiology of tick-borne encephalitis virus: cross-protection between European and Far Eastern subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Protection against tick-borne encephalitis virus isolated in Japan by active and passive immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Evaluation of European tick-borne encephalitis virus vaccine against recent Siberian and far-eastern subtype strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Characterization of neutralizing antibodies to Far Eastern of tick-borne encephalitis virus subtype and the antibody avidity for four tick-borne encephalitis vaccines in human

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

A controlled trial of tick-borne encephalitis vaccination in patients with multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Two severe cases of tick-borne encephalitis despite complete active vaccination--the significance of neutralizing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

TBE infection in an incomplete immunized person at-risk who lives in a high-endemic area--impact on current recommendations for immunization of high-risk groups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

Vaccine failures after active immunisation against tick-borne encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.089

10.1016/J.VACCINE.2011.07.089

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21843576%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference